December 1, 2016 - By Adrian Mccoy · 0 Comments
Owens & Minor Inc (NYSE:OMI) institutional sentiment decreased to 1.22 in 2016 Q2. Its down -0.22, from 1.44 in 2016Q1. The ratio has dropped, as 147 investment professionals increased or opened new equity positions, while 102 sold and reduced positions in Owens & Minor Inc. The investment professionals in our partner’s database now possess: 59.84 million shares, down from 65.77 million shares in 2016Q1. Also, the number of investment professionals holding Owens & Minor Inc in their top 10 equity positions decreased from 1 to 0 for a decrease of 1. Sold All: 30 Reduced: 72 Increased: 114 New Position: 33.
Owens & Minor, Inc. is a global healthcare services company. The company has a market cap of $2.07 billion. The Firm provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. It has a 18.53 P/E ratio. The Firm operates in two divisions: Domestic and International.
About 154,858 shares traded hands. Owens & Minor, Inc. (NYSE:OMI) has declined 7.25% since April 28, 2016 and is downtrending. It has underperformed by 13.17% the S&P500.
Analysts await Owens & Minor, Inc. (NYSE:OMI) to report earnings on February, 13. They expect $0.50 EPS, down 10.71% or $0.06 from last year’s $0.56 per share. OMI’s profit will be $30.43M for 17.01 P/E if the $0.50 EPS becomes a reality. After $0.51 actual EPS reported by Owens & Minor, Inc. for the previous quarter, Wall Street now forecasts -1.96% negative EPS growth.
According to Zacks Investment Research, “Owens & Minor, Inc. is one of the nation’s largest distributors of national name brand medical/surgical supplies. With distribution centers located throughout the United States, the company serves hospitals, integrated healthcare systems and group purchasing organizations. In addition to a diverse product offering, Owens & Minor offers innovative services in supply chain management, logistics and technology, helping customers control healthcare costs and improve inventory management.”
Dean Capital Management holds 1.94% of its portfolio in Owens & Minor, Inc. for 37,760 shares. Pura Vida Investments Llc owns 111,400 shares or 1.77% of their US portfolio. Moreover, Sector Gamma As has 1.53% invested in the company for 202,342 shares. The Pennsylvania-based Irving Magee Investment Management has invested 1.42% in the stock. Adirondack Research & Management Inc., a New York-based fund reported 98,987 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 0 buys, and 3 selling transactions for $622,658 net activity.
Ratings analysis reveals 0 of Owens & Minor’s analysts are positive. Out of 5 Wall Street analysts rating Owens & Minor, 0 give it “Buy”, 3 “Sell” rating, while 2 recommend “Hold”. The lowest target is $32 while the high is $37. The stock’s average target of $35 is 2.91% above today’s ($34.01) share price. OMI was included in 6 notes of analysts from August 25, 2015. UBS initiated the stock with “Sell” rating in Thursday, October 6 report. The stock of Owens & Minor, Inc. (NYSE:OMI) earned “Underperform” rating by Bank of America on Monday, November 7. Zacks downgraded the shares of OMI in a report on Tuesday, August 25 to “Hold” rating. Robert W. Baird downgraded the shares of OMI in a report on Thursday, April 21 to “Underperform” rating. RBC Capital Markets maintained it with “Sector Perform” rating and $36 target price in Monday, December 7 report.
Owens & Minor, Inc., incorporated on December 20, 1993, is a global healthcare services company. The Firm provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. The Firm operates in two divisions: Domestic and International. The Domestic segment includes all functions relating to its role as a medical supply logistics firm providing distribution; kitting, including Medical Action Industries Inc. (Medical Action), and logistics services to healthcare providers and manufacturers in the United States. The International segment consists of Movianto Group (Movianto) and ArcRoyal. The Firm serves clients with a service portfolio that covers procurement, inventory management, delivery and sourcing for the healthcare market. With fully developed networks in the United States and Europe, it serves a customer base, ranging from hospitals, integrated healthcare systems, group purchasing organizations and the United States federal government, to manufacturers of life-science and medical devices and supplies, including pharmaceuticals in Europe.
More recent Owens & Minor, Inc. (NYSE:OMI) news were published by: Forbes.com which released: “Owens & Minor is Oversold” on August 09, 2016. Also Forbes.com published the news titled: “Owens & Minor Becomes Oversold” on April 20, 2016. Businesswire.com‘s news article titled: “Owens & Minor Names Rony C. Kordahi to Serve as Executive Vice President …” with publication date: April 04, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Adrian Mccoy